Table 1.
Baseline characteristics of patients.
| Characteristic | HCC MVI (-) (n = 178) |
HCC MVI (+) (n = 144) |
P-value |
|---|---|---|---|
| Age (year) | 0.304 | ||
| Mean ± SD | 58 ± 11 | 57 ± 9 | |
| Range | 20–81 | 29–74 | |
| Male/female | 143/35 | 129/15 | 0.037 |
| Etiology of liver disease | |||
| Hepatitis B | 137 | 120 | |
| Hepatitis C | 3 | 5 | |
| Alcohol | 1 | 0 | |
| NAFLD | 12 | 5 | |
| Absence | 25 | 14 | |
| AFP (ng/l) | 28 ± 10 | 506 ± 8 | <.001* |
| CA 19-9 | 38 ± 7 | 425 ± 19 | 0.784 |
| CEA | 4.8 ± 1.3 | 9.7 ± 5.5 | 0.635 |
| Tumor size (mm) | <0.001* | ||
| Mean ± SD | 32.3 ± 23.3 | 48.4 ± 30.6 | |
| Range | 9–144 | 6–176 | |
HCC, hepatocellular carcinoma; MVI, microvascular invasion; AFP, Alpha-fetoprotein; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; NAFLD, non-alcoholic fatty liver disease.